argenx SE (ARGX) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Argenx to Present at TD Cowen 45th Annual Healthcare Conference
GlobeNewswire01:00 ET
Earnings Preview: Argenx SE to Report Financial Results on February 27
Moomoo NewsFeb 21 20:00 ET
Argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025
GlobeNewswireFeb 20 01:00 ET
Here's Why Argenx SE (ARGX) Rose in Q4
Yahoo FinanceFeb 19 10:58 ET
Argenx Se (ARGX) Receives a Buy From Jefferies
TipRanksFeb 5 08:35 ET · Ratings
Analysts' Top Healthcare Picks: Argenx Se (ARGX), Travere Therapeutics (TVTX)
TipRanksFeb 4 06:35 ET · Ratings

Comments

Money Thrill

Nov 12, 2024 03:38

European Morning news [MarketDevil]

$argenx SE (ARGX.US)$ (ABM FN) China's regulator has approved the Supplemental Biologics License Application for Vyvgart Hytrulo for the treatment of adults suffering from CIDP. The biotech company announced this after the close.
This approval followed the Adhere study.This concerns an injection of 1,000 milligrams that can be administered once a week. About 50,000 people in China suffer from CIDP.
“It is the first and only treatment approved in China for CIDP,”...

Money Thrill

Nov 2, 2024 14:19

European News from journal HLN (LeatestNewsJournal)

$argenx SE (ARGX.US)$ Last quarter, the company recorded a net profit of 91.4 million euros, compared to a net loss of 72.6 million euros in the same period last year. After nine months there is a net profit of 58.9 million euros against a net loss of 195.9 million euros.
The difference between the operational results and the net result is mainly made up of the financial results and the taxes on the result. At the end of September, Argenx still h...

1

Meltyy

Jun 25, 2024 07:02

🔔 FDA PDUFA Update…

🔥 3 PDUFA decisions this week! 👇
📌 This week’s PDUFAs:
$Merck & Co (MRK.US)$ : 🤔
⇨ Patritumab deruxtecan
‣ Non-small cell lung carcinoma
‣ PDUFA date: 6/26/24 (BLA)
$Verona Pharma (VRNA.US)$ : 🤔
⇨ Ensifentrine (Nebulized)
‣ Chronic obstructive pulmonary disease
‣ PDUFA date: 6/26/24 (NDA)
$Genmab (GMAB.US)$ : 🤔
⇨ EPKINLY® (Epcoritamab)
‣ Follicular lymphoma
‣ PDUFA date: 6/28/24 (sBLA)
🗓️ Last week’s PDUFAs:
$Merck & Co (MRK.US)$ : Approved 6/17 🎉
⇨ CAPVAXIVE (V116)
‣ Pneumo...